Bayer (Product Portfolio for Products based on Lormetazepam) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Bayer (Product Portfolio for Products based on Lormetazepam) General Information

Description

Portfolio of products based on Lormetazepam intended for Italy and Japan.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Germany
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer (Product Portfolio for Products based on Lormetazepam) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer (Product Portfolio for Products based on Lormetazepam)‘s full profile, request access.

Request a free trial

Bayer (Product Portfolio for Products based on Lormetazepam) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer (Product Portfolio for Products based on Lormetazepam)‘s full profile, request access.

Request a free trial

Bayer (Product Portfolio for Products based on Lormetazepam) FAQs

  • Where is Bayer (Product Portfolio for Products based on Lormetazepam) headquartered?

    Bayer (Product Portfolio for Products based on Lormetazepam) is headquartered in Germany.

  • What industry is Bayer (Product Portfolio for Products based on Lormetazepam) in?

    Bayer (Product Portfolio for Products based on Lormetazepam)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Bayer (Product Portfolio for Products based on Lormetazepam) a private or public company?

    Bayer (Product Portfolio for Products based on Lormetazepam) is a Private company.

  • What is Bayer (Product Portfolio for Products based on Lormetazepam)’s current revenue?

    The current revenue for Bayer (Product Portfolio for Products based on Lormetazepam) is .

  • Who are Bayer (Product Portfolio for Products based on Lormetazepam)’s investors?

    Bayer has invested in Bayer (Product Portfolio for Products based on Lormetazepam).

  • When was Bayer (Product Portfolio for Products based on Lormetazepam) acquired?

    Bayer (Product Portfolio for Products based on Lormetazepam) was acquired on 07-Mar-2022.

  • Who acquired Bayer (Product Portfolio for Products based on Lormetazepam)?

    Bayer (Product Portfolio for Products based on Lormetazepam) was acquired by Neopharmed Gentili.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process